SYNLAB company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

synlab.com

Stage

Divestiture

Total Raised

$265M

Investors Count

3

Deal Terms

2

Portfolio Exits

1

SYNLAB Funding, SYNLAB Valuation & SYNLAB Revenue

5 Fundings

SYNLAB's latest funding round was a IPO for on April 28, 2021.

SYNLAB's valuation in April 2017 was $1,325M.

SYNLAB's latest post-money valuation is from April 2017.

Sign up for a free trial to see SYNLAB's valuations in June 2015 and more.

SYNLAB's 2016 revenue was $1.71B. SYNLAB's most recent revenue is from 2016.

Sign up for a free trial to see revenue data from 2016 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/28/2021

IPO

0

FY undefined

1

4/12/2017

Corporate Minority - II

$99M

$1,325M

$0.00B

((9.99x))

FY 1234

10

12/16/2016

Corporate Minority

$1.71B

FY 2016

10

6/26/2015

Acq - Fin

$99M

$0.00B

((9.99x))

FY 1234

10

9/2/2009

Private Equity

0

FY undefined

10

Date

4/28/2021

4/12/2017

12/16/2016

6/26/2015

9/2/2009

Round

IPO

Corporate Minority - II

Corporate Minority

Acq - Fin

Private Equity

Amount

$99M

Investors

Valuation

$1,325M

$99M

Revenue

0

FY undefined

$0.00B

((9.99x))

FY 1234

$1.71B

FY 2016

$0.00B

((9.99x))

FY 1234

0

FY undefined

Sources

1

10

10

10

10

SYNLAB Deal Terms

2 Deal Terms

SYNLAB's deal structure is available for 2 funding rounds, including their Corporate Minority - II from April 12, 2017.

Round

Corporate Minority - II

Acq - Fin

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Corporate Minority - II

$99M

$99M

$99M

$99M

$99M

$99M

Acq - Fin

$99M

$99M

$99M

$99M

SYNLAB Investors

3 Investors

SYNLAB has 3 investors. Novo Holdings invested in SYNLAB's Corporate Minority - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/16/2016

4/12/2017

2
Corporate Minority, Corporate Minority - II (2017)

Holding Company

Denmark

00/00/0000

00/00/0000

Cinven

Subscribe to see more

Private Equity

United Kingdom

00/00/0000

00/00/0000

BC Partners

Subscribe to see more

Private Equity

United Kingdom

First funding

12/16/2016

00/00/0000

00/00/0000

Last Funding

4/12/2017

00/00/0000

00/00/0000

Investor

Cinven

BC Partners

Rounds

2
Corporate Minority, Corporate Minority - II (2017)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Holding Company

Private Equity

Private Equity

Location

Denmark

United Kingdom

United Kingdom

SYNLAB Acquisitions

7 Acquisitions

SYNLAB acquired 7 companies. Their latest acquisition was Sistemas Genomicos on January 07, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/7/2022

$99M

Acquired

1

8/2/2021

Subscribe to see more

$99M

Subscribe to see more

10

8/2/2021

Subscribe to see more

$99M

Subscribe to see more

10

7/26/2021

Subscribe to see more

$99M

Subscribe to see more

10

9/8/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/7/2022

8/2/2021

8/2/2021

7/26/2021

9/8/2018

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

SYNLAB Portfolio Exits

1 Portfolio Exit

SYNLAB has 1 portfolio exit. Their latest portfolio exit was SGS Analytics on November 10, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/10/2020

Divestiture

$99M

9

Date

11/10/2020

Exit

Divestiture

Companies

Valuation

$99M

Acquirer

Sources

9

You May Also Like

Cyted Logo
Cyted

Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. The company utilizes AI and biomarkers to improve patient outcomes. It was founded in 2020 and is based in Cambridge, England.

L
LabCorp

Laboratory Corporation of America Holdings (NYSE: LH), dba LabCorp, provides medical laboratory tests and services through a national network of primary clinical laboratories. Its clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies.

U
Unilabs

Unilabs is a European supplier of laboratory and radiology services to private and public health care units, government bodies, insurance companies, the general public and to parts of the pharmaceutical industry. It covers the full spectrum of diagnostics across laboratory, imaging and pathology services at scale and operates in twelve countries in Europe. It is based in Geneva, Switzerland.On December 3rd, 2021, Unilabs was acquired by AP Moller Holding. The terms of the transaction were not disclosed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.